https://www.rippletherapeutics.com/practice_area 1.0 monthly 2026-03-27 https://www.rippletherapeutics.com/contact 1.0 monthly 2022-09-15 https://www.rippletherapeutics.com 1.0 monthly 2026-03-27 https://www.rippletherapeutics.com/about-old 1.0 monthly 2025-11-25 https://www.rippletherapeutics.com/news_updates 1.0 monthly 2022-09-15 https://www.rippletherapeutics.com/careers 1.0 monthly 2025-11-25 https://www.rippletherapeutics.com/about 1.0 monthly 2026-03-27 https://www.rippletherapeutics.com/ripple-abbvie-ophthalmic-drug-delivery-panel 0.8 monthly 2026-02-12 https://www.rippletherapeutics.com/ripple-therapeutics-enters-collaboration-with-bausch---lomb 0.8 monthly 2025-11-25 https://www.rippletherapeutics.com/ois-xv 0.8 monthly 2026-01-15 https://www.rippletherapeutics.com/overview-of-the-epidel-prodrug-engineered-sustained-drug-delivery-platform-wendy-naimark-cto-cofounder 0.8 monthly 2025-11-25 https://www.rippletherapeutics.com/why-a-homegrown-biotech-sector-matters-for-canada 0.8 monthly 2025-10-22 https://www.rippletherapeutics.com/ripple-is-featured-in-lsos-success-stories 0.8 monthly 2025-05-02 https://www.rippletherapeutics.com/ripple-therapeutics-announces-evaluation-and-licensing-agreements-with-glaukos 0.8 monthly 2024-10-15 https://www.rippletherapeutics.com/ripple-therapeutics-presents-at-euretina 0.8 monthly 2024-09-23 https://www.rippletherapeutics.com/ripple-therapeutics-announces-collaboration-and-option-to-license-agreement-with-abbvie-to-develop-next-generation-therapies-for-glaucoma-management 0.8 monthly 2024-09-17 https://www.rippletherapeutics.com/ripple-therapeutics-presents-at-retina-world-conference 0.8 monthly 2024-07-09 https://www.rippletherapeutics.com/ripple-therapeutics-presents-at-arvo-2024 0.8 monthly 2024-05-17 https://www.rippletherapeutics.com/ripple-therapeutics-presents-at-eyecelerator-ascrs-2024 0.8 monthly 2024-04-16 https://www.rippletherapeutics.com/ripple-therapeutics-presents-results-of-ripple-1-at-ophthalmology-conferences 0.8 monthly 2024-04-15 https://www.rippletherapeutics.com/hovione-and-ripple-enter-strategic-partnership-to-expand-epidel-platform-into-non-ophthalmic-space 0.8 monthly 2023-03-20 https://www.rippletherapeutics.com/ripple-therapeutics-is-named-best-workplacestm-for-start-ups 0.8 monthly 2023-01-25 https://www.rippletherapeutics.com/ripple-therapeutics-appoints-jonathan-talamo-m-d-to-chair-of-the-board 0.8 monthly 2022-11-29 https://www.rippletherapeutics.com/tom-reeves-president-ceo-presents-during-ois-retina-on-july-13th-at-the-edison-ballroom-nyc 0.8 monthly 2022-08-12 https://www.rippletherapeutics.com/news/ripple-therapeutics-is-a-great-place-to-work 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ian-parrag-phd-director-r-d-presents-one-engineers-path-in-product-development-towards-controlled 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-work-on-anti-fibrotic-coatings-has-been-published-in-biomaterials 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/ike-ahmed-md-frcsc-presents-preclinical-evaluation-of-trc-1119-a-surface-eroding-intracameral 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-receives-funding-support-to-advance-r-d-efforts-in-ophthalmic-therapeutics 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-announces-new-vice-president-operations 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-tom-reeves-to-present-at-bio-ceo-investor-conference 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripples-president-ceo-tom-reeves-presents-at-ois-drug-deliver-forum-dec-2-2021 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/kyle-battiston-phd-sr-engineer-mgr-wendy-naimark-phd-cto-will-be-presenting-at-2021-crs-virtual 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/-ripples-president-ceo-tom-reeves-presents-at-tsx-life-sciences-investor-day 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/ripple-therapeutics-research-on-polymer-free-drug-delivery-published-in-nature-communications 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/new-method-can-improve-drug-delivery-in-implants 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-appoints-jonathan-talamo-m-d-to-board-of-directors 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-announces-first-patient-treated-in-phase-ii-trial-evaluating-ibe-814-ivt-in 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripples-ceo-tom-reeves-presents-at-2021-biotecanada-investor-summit 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/sheardown-lab-and-ripple-therapeutics-receive-nserc-grant-to-improve-treatment-for-millions-with 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-presents-at-2021-obio-investment-summit-canadas-premier-health-science-investment-event 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/tom-reeves-president-ceo-of-ripple-therapeutics-presents-at-biotech-showcase 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/ripple-therapeutics-lead-candidate-attracts-strategic-investment-and-licensing-partner 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-therapeutics-secures-licensing-agreement-and-series-a-financing-led-by-théa-open-innovation 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ripple-presents-at-arvo-2020 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/ripple-series-a-financing-watch-this 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/ripple-therapeutics-pursues-financing-for-phase-2-intravitreal-implant-trial-and-epidel-platform 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/interface-biologics-announces-spinout-ripple-therapeutics- 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/ibi-poster-at-aua-2019-in-vitro-evaluation-of-novel-surface-modifying-molecules-to-prevent-bacterial-adhesion-to-urological-devices 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/fresenius-medical-care-receives-fda-breakthrough-device-designation-for-new-dialysis-system-to-prevent-blood-clotting-without-the-use-of-blood-thinners 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/pharmacokinetics-and-pharmacodynamics-of-a-novel-dexamethasone-intravitreal-implant-ibi-abstract-presented-at-arvo-2019 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/interface-biologics-announces-sale-of-surface-modification-business-to-evonik 0.8 monthly 2022-08-04 https://www.rippletherapeutics.com/news/interface-biologics-presents-at-oisaao 0.8 monthly 2022-08-05 https://www.rippletherapeutics.com/news/wendy-naimark-phd-v-p-r-d-speaks-on-retinal-drug-delivery-solutions-at-oisasrs2019 0.8 monthly 2022-08-05